|
Cours en clôture
21/08/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
7,080 CNY
|
+9,94%
|
 |
+17,22%
|
-3,93%
|
|
01/06 |
Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025
| | |
07/05 |
Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug
| | |
29/04 |
Beijing SL Pharmaceutical Co., Ltd. announces Annual dividend, payable on July 22, 2026
| | |
28/04 |
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
28/04 |
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
| | |
23/03 |
Beijing SL Pharmaceutical Co., Ltd.(XSEC:002038) dropped from FTSE All-World Index
| | |
26/10/25 |
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
25/08/25 |
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
23/05/25 |
Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2024
| | |
22/04/25 |
Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2024
| | |
21/04/25 |
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
02/04/25 |
Beijing SL Pharmaceutical Secures Drug Registration for Regorafenib Tablets
| | |
25/10/24 |
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
| | |
25/08/24 |
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
| | |
01/07/24 |
Beijing SL Pharmaceutical Gets Nod to Market Epalrestat Tablets
| | |
28/06/24 |
Beijing SL Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 July 2024
| | |
21/06/24 |
Suzhou Pulekang Pharmaceutical Technology Co., Ltd announced that it expects to receive CNY 40 million in funding from Beijing SL Pharmaceutical Co., Ltd.
| | |
24/05/24 |
Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023
| | |
24/05/24 |
Beijing SL Pharmaceutical Co., Ltd. Announces Board Appointments
| | |
24/04/24 |
Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023
| | |
23/04/24 |
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
| | |
25/10/23 |
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
| | |
20/10/23 |
Chinese Shares Extend Losses on Middle East Conflict; Beijing SL Pharmaceutical Slumps Despite Drug Trial Approval
| | |
20/10/23 |
Beijing SL Pharmaceutical Gets Nod to Trial Anti-Hepatitis C Drug; Shares Drop 10%
| | |
17/10/23 |
Kanghui Pharma Denies Speculations of Unit’s Involvement in Production of Weight-Loss Drugs
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
